|
Real-time Estimate
Cboe BZX
09:56:20 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 29.66 USD | +4.68% |
|
+12.04% | +7.40% |
| 08-19 | Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder | RE |
| 08-05 | BofA Adjusts Price Target on Beam Therapeutics to $43 From $47 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.68% | +12.04% | +18.75% | -0.07% | +7.40% | +81.08% | +28.26% | -70.82% | - | 2.83B | |
| +1.26% | +4.95% | +6.15% | +20.81% | +10.41% | +3.67% | +25.46% | -22.74% | +218.22% | 51.21B | |
| +1.47% | -0.20% | +14.62% | +39.17% | +170.63% | +504.32% | +550.45% | +702.53% | - | 45.35B | |
| -0.61% | +8.31% | +21.93% | +60.48% | +15.34% | +38.27% | +18.71% | +0.49% | +243.53% | 42.84B | |
| -0.01% | +1.39% | +14.85% | +23.76% | +23.20% | +21.27% | +88.64% | +29.01% | +1,236.75% | 42.29B | |
| +0.88% | -3.48% | +9.23% | +2.52% | +12.54% | +17.20% | +53.83% | -16.47% | +148.72% | 32.15B | |
| -0.43% | +4.72% | +4.88% | +44.05% | +10.06% | +32.42% | +137.91% | +242.18% | +2,132.36% | 17.31B | |
| +1.44% | +2.53% | +0.68% | +6.47% | - | - | - | - | - | 16.55B | |
| +0.87% | +6.09% | +10.43% | +16.86% | +18.43% | +10.73% | +32.30% | -37.61% | +100.87% | 14.84B | |
| -0.29% | +7.45% | +33.74% | +91.41% | +50.39% | +82.80% | +49.70% | -30.70% | +264.42% | 14.25B | |
| -1.44% | +2.88% | +1.82% | +50.95% | -5.69% | +0.06% | -32.95% | -31.71% | +128.99% | 13.38B | |
| +1.97% | +33.07% | +53.08% | +40.77% | +11.24% | -13.46% | - | - | - | 11.94B | |
| -6.50% | -10.48% | +16.43% | +73.00% | +57.79% | +49.04% | +57.24% | -48.50% | - | 11.27B | |
| -0.10% | +0.13% | +0.97% | +50.75% | +22.96% | +27.52% | -9.79% | -42.18% | +175.25% | 11.35B | |
| +4.59% | -0.29% | -9.36% | -10.86% | -14.78% | +56.88% | +503.53% | +258.74% | +2,530.77% | 10.71B | |
| +0.80% | +3.13% | +20.78% | +8.79% | +29.41% | +712.59% | +1,595.25% | +38.20% | - | 10.28B | |
| +0.03% | +0.20% | +0.42% | +62.84% | +78.65% | +265.04% | +467.77% | - | - | 10.17B | |
| +1.14% | -0.09% | +15.96% | +57.23% | +79.99% | +176.37% | +689.16% | +220.36% | +1,367.79% | 10.01B | |
| +1.16% | +2.58% | +13.14% | +54.15% | +60.02% | +197.73% | +533.96% | +121.27% | - | 10.07B | |
| +1.96% | +6.07% | +13.01% | -16.87% | -20.06% | +51.22% | +56.85% | +59.94% | +108.23% | 10.31B | |
| Average | +0.63% | +2.27% | +13.08% | +33.81% | +32.52% | +121.83% | +269.24% | +80.71% | +721.32% | 19.46B | |
| Weighted average by Cap. | +0.48% | +2.63% | +12.91% | +33.58% | +39.22% | +117.82% | +209.90% | +114.61% | +615.14% |
- Stock Market
- Stocks
- BEAM Stock
- Sector Beam Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
